Technology Transfer Fee Sample Clauses
A Technology Transfer Fee clause establishes the obligation for one party to pay a fee in exchange for the transfer of specific technological knowledge, processes, or intellectual property from another party. This fee typically applies when proprietary technology, know-how, or technical documentation is shared to enable manufacturing, development, or commercialization by the receiving party. By clearly defining the payment terms and scope of the technology being transferred, this clause ensures both parties understand their financial and operational commitments, thereby facilitating smooth collaboration and reducing disputes over compensation for valuable technological assets.
POPULAR SAMPLE Copied 18 times
Technology Transfer Fee. Within thirty (30) days of the Completion of Technology Transfer, Kiniksa shall pay Biogen a one-time, non-refundable, non-creditable technology transfer fee in the amount of Five Hundred Thousand Dollars ($500,000) (the “Technology Transfer Fee”), payable by electronic funds transfer of immediately available funds to an account or accounts specified to Kiniksa by Biogen in writing at least five (5) Business Days prior to the date thereof.
Technology Transfer Fee. Videocon shall pay CopyTele a non-refundable, non-creditable Technology Transfer Fee of US $11,000,000.00, as follows:
a. US $2,000,000, 15 days after the Effective Date.
b. US $1,500,000, nine (9) months after the Effective Date.
c. US $2,500,000, eighteen (18) months after the Effective Date.
d. US $5,000,000, twenty-seven (27) after the Effective Date.
Technology Transfer Fee. In consideration of the licenses granted by DSM to Martek herein and the transfer of technologies pursuant to the provisions of Section 7.5(b), Martek shall pay to DSM a one-time non refundable fee of ten million US Dollars ($10,000,000.00), four million US Dollars ($4,000,000.00) of which shall be payable within five (5) days of the Signing Date, four million US Dollars ($4,000,000.00) of which shall be payable on November 2, 2004 and two million US Dollars ($2,000,000.00) of which shall be payable on November 2, 2005.
Technology Transfer Fee. Kirin shall pay Dendreon a non-refundable technology transfer fee in the amount of eight million U.S. dollars ($8,000,000), payable in accordance with the following schedule:
(a) Five million dollars ($5,000,000) in cash on December 10, 1998 (the "Effective Date"), receipt of which is hereby acknowledged.
(b) Three million dollars ($3,000,000) in cash within thirty (30) days of the initiation of the first Phase II clinical study for the first Kirin Product. For purposes of this
Technology Transfer Fee. Within […***…] of the Effective Date, CRISPR shall pay to EC a non-creditable, non-refundable, one-time technology transfer fee of CHF […***…].
Technology Transfer Fee. In the event a Sale/Merger Event occurs prior to October 20, 2006, BioForm shall pay the sum of Two Million U.S. Dollars (US $2,000,000) to Artes (the “Technology Transfer Fee”). The Technology Transfer Fee shall be paid within ten (10) business days following such Sale/Merger Event in immediately available funds via wire transfer to a bank in the United States for the account of Artes as set forth in Exhibit C.
Technology Transfer Fee. 20 5.2 Royalties on Sales of Kirin Products.............................. 20 5.3 Royalties on Sales of Licensed Dendreon Products.................. 21 5.4 Royalties on Dendreon Sales of Licensed Kirin Products............ 22 5.5
Technology Transfer Fee. Kirin shall pay Dendreon a non-refundable technology transfer fee in the amount of eight million U.S. dollars ($8,000,000), payable in accordance with the following schedule:
(a) Five million dollars ($5,000,000) in cash on the Effective Date.
(b) Three million dollars ($3,000,000) in cash within [ * ] of the [ * ] of the [ * ] for the [ * ]. For purposes of this Section, [ * ] means [ * ] on which [ * ] in [ * ] to [ * ] the [ * ]. The foregoing technology transfer fee payments are inclusive of such withholding taxes as are finally ascertained to be due and payable by Kirin on account of Dendreon and shall be made by wire transfer to an account designated by Dendreon for such purpose.
Technology Transfer Fee. VIA shall pay Abbott a non-refundable, non-creditable fee of One Million United States Dollars (US$1,000,000) within thirty (30) days of completion of the transfer of the Licensed Technology listed in Appendix B.
Technology Transfer Fee. In consideration of Transmeta’s delivery of the Transmeta Technology Deliverables and Technology Transfer Training pursuant to Section 3.1 during the Technology Transfer Services Period, Toshiba will pay Transmeta a one-time technology transfer fee of [* * *], which fee will be payable (i) within [* * *] following the execution of this Agreement or (ii) by [* * *], whichever is later. The technology transfer fee payable by Toshiba hereunder is non-refundable, and is not creditable against the royalties which may become payable by Toshiba under Section 2.5. This payment is in no way dependent upon Toshiba successfully manufacturing a LongRun2 Product or “bringing up” a LongRun2 Product production process.